U.S. STOCKS Baudax Bio , GATX Corp, Verb Technology, Decibel Therapeutics

<html xmlns="http://www.w3.org/1999/xhtml"><head><title>BUZZ-U.S. STOCKS ON THE MOVE-Baudax Bio , GATX Corp, Verb Technology, Decibel Therapeutics</title></head><body>

Eikon search string for individual stock moves: STXBZ

The Day Ahead newsletter: https://refini.tv/3LI4BU7

The Morning News Call newsletter: https://refini.tv/3dKUyB8

Wall Street slipped on Tuesday after industry bellwethers 3M, Johnson & Johnson and GE warned of a challenging year ahead, while a technical issue at the New York Stock Exchange briefly halted trading in some stocks shortly after the opening bell..N

At 13:33 P.M. ET, the Dow Jones Industrial Average .DJI was up 0.24% at 33,710.52. The S&P 500 .SPX was !RIC {.SPX} is invalid and the Nasdaq Composite .IXIC was down 0.12% at 11,351.243.

The top three S&P 500 .PG.INX percentage gainers:
** PACCAR Inc PCAR.O, up 7.5%
** Synchrony Financial SYF.N, up 4.1%
** Caesars Entertainment Inc CZR.OQ, up 3.7%

The top three S&P 500 .PL.INX percentage losers:
** Brown & Brown Inc BRO.N, down 5.6%
** Enphase Energy Inc ENPH.O, down 5.3%
** 3M Company MMM.N, down 5.2%

The top NYSE .PG.N percentage gainer:
** Yalla Group Ltd YALA.N, up 18%

The top three NYSE .PL.N percentage losers:
** Satixfy Communications Ltd SATX.N, down 72.6%
** Forestar Group Inc FOR.N, down 10.2%
** PennantPark Floating Rate Capital Ltd PFLT.N, down 9.1%

The top three Nasdaq .PG.O percentage gainers:
** bioAffinity Technologies Inc BIAF.O, up 118.9%
** Baudax Bio BXRX.O, up 35.2%
** Grom Social Enterprises Inc GROM.O, up 33.1%

The top two Nasdaq .PL.O percentage losers:
** Scilex Holding Company SCLX.O, down 32.3 %
** Altamira Therapeutics Ltd CYTO.O, down 29.5 %

** Travelers Companies Inc TRV.N: up 3.3%

BUZZ - Gains on Q4 revenue beat nL4N3492DV

** Advanced Micro Devices Inc AMD.O: down 3.1%
BUZZ - Falls as Bernstein downgrades on PC outlook woes nL4N3491BH

** Blackstone Inc BX.N: up 1.0%
BUZZ - J.P.Morgan says Blackstone good investment over next 12 months, hikes to 'overweight' nL4N349149

** Lululemon Athletica Inc LULU.O: down 1.6%
BUZZ - Slips as Bernstein downgrades to 'underperform' on slowing earnings nL4N3491GC

** HighPeak Energy Inc HPK.O: up 4.8%
BUZZ - Rises after announcement of potential sale nL4N3491HD

** Lyft Inc LYFT.O: up 1.5%
BUZZ - Gains on KeyBanc upgrade to 'overweight' nL4N3491KW

** Allogene Therapeutics Inc ALLO.O: up 15.6%

BUZZ - JP Morgan upgrades Allogene, expects greater focus on lead cancer program nL4N3491GO

** Raytheon Technologies Corp RTX.N: up 2.0%

BUZZ - Rises on beating Q4 profit estimate nL4N3491OR

** PennantPark Floating Rate Capital Ltd PFLT.N: down 9.1%

BUZZ - Slides on pricing stock deal nL1N3490PC

** D.R. Horton Inc DHI.N: up 2.1%

BUZZ - Rises as co beats Q1 profit estimates nL4N3491QJ

** Verb Technology Company Inc VERB.O: down 48.4%

BUZZ - Falls on plans to raise equity nL4N3491JN

** Virgin Galactic Holdings Inc SPCE.N: up 1.0%

BUZZ - Near-term visibility remains cloudy - KeyBanc nL4N3491RK

** Alphabet Inc GOOGL.O: down 1.2%

BUZZ - Leads declines among major growth stocks nL4N3491OE

** CymaBay Therapeutics Inc CBAY.O: up 17.4%

BUZZ - Jumps on pricing upsized stock offering at premium nL1N3490UW

** Polypid Ltd PYPD.O: up 6.1%

BUZZ - Surges on regulatory pathway for infection treatment nL4N3491SD

** Union Pacific Corp UNP.N: down 2.7%

BUZZ - Slips on Q4 profit fall nL4N3491TR

** PACCAR Inc PCAR.O: up 7.5%

BUZZ - Gains as Q4 profit beats estimates nL4N3491YU

** Cullinan Oncology Inc CGEM.O: up 6.2%

BUZZ - Rises on FDA's nod for cancer drug trial in humans nL4N3491YV

** 3M Co MMM.N: down 5.2%
BUZZ - Falls on plans to cut 2,500 jobs after quarterly profit drops nL4N3491ZC

** Full Truck Alliance Co YMM.N: down 7.6%

BUZZ - Falls after short seller accuses of misconduct nL4N34924O

** Peloton Interactive Inc PTON.O: down 4.1%

BUZZ - Falls after brokerage UBS says app users declined nL4N34926O

** Magna International Inc MGA.N: down 6.9%

BUZZ - Expects weak margins as sales drop, costs rise nL4N3491JI

** Pliant Therapeutics Inc PLRX.O: up 8.6%

BUZZ - Rises after brokerages boost PT nL4N34928E

** Altamira Therapeutics Ltd CYTO.O: down 29.5%

BUZZ - Slumps as nasal spray fails COVID study nL4N349271

** Finch Therapeutics Group Inc FNCH.O: down 6.3%

BUZZ - Falls on discontinuing bacterial infection drug trial nL4N3492AC

** Civitas Resources Inc CIVI.N: up 1.6%

BUZZ - Gains on $300 mln share buyback plan nL4N3492AY

** Baudax Bio Inc BXRX.O: up 35.2%

BUZZ - Gains on positive interim analysis of study data on muscle relaxant drug nL4N34925Y

** GATX Corp GATX.N: up 4.1%

BUZZ - Soars on Q4 profit beat nL4N3492D5

** Decibel Therapeutics Inc DBTX.O: up 12.3%

BUZZ - Rises on regulatory nod to begin hearing loss therapy trials in UK nL4N3492CX

** TG Therapeutics Inc TGTX.O: up 12.6%

BUZZ - Up as Evercore raises PT nL4N3492EL

** Primo Water Corp PRMW.N: up 2.9%

BUZZ - Names new finance chief, shares gain nL4N3492G4

The 11 major S&P 500 sectors:

Communication Services


down 0.34%

Consumer Discretionary


down 0.06%

Consumer Staples


up 0.28%



down 0.53%



up 0.37%



down 0.86%



up 0.68%

Information Technology


up 0.07%



down 0.32%

Real Estate


up 0.34%



up 0.30%

(Compiled by Rajarshi Roy and Mariam E Sunny)


Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

We are using cookies to give you the best experience on our website. Read more or change your cookie settings.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.